Register

Site

National Stroke Association (NSA)

Content

The Stroke Research Summary consists of a listing of about 30 clinical trials. Sources of information vary from pharmaceutical companies and individual hospital centers to journals and websites, such as PhRMA New Medicines in Development. Some provide very little detail, others more. The sponsor/co-ordinating center is named only, without full contact details.
(Paid) membership of the Stroke Center Network allows ‘enrollment into NSA’s clinical trial data base and access to ongoing information and perspectives on clinical trials’. These services were not assessed during this site visit. Details are given of other benefits of membership.

The NSA’s Stroke Center Network is an alliance of clinicians, researchers, and healthcare professionals who are committed to developing centers of excellence for stroke management.

Other information available

The site’s professional pages provide information on the NSA’s Clinical Trials Acceleration Program. A Treatment link on the home page gives access to a list of ‘Trial Agents for Acute Treatment’.
The professional pages also give information on stroke prevention programs, professional meetings, fellowships, publications, educational materials and library services.

Access

Access to the main site is free, but the Stroke Center Network pages include an area for members only (membership fee payable and authorisation required).
Access to the Stroke Research Summary page is via the ‘Professional Pages’ button, then click on Clinical Trials Acceleration Program, and the Stroke Research Summary link at the bottom of this page. Although the site states that the Stroke Research Summary is for professionals only, there is unrestricted access to it.

Comments

Paid membership of the Stroke Center Network confers access to more information on ongoing trials. There are two search facilities: one for the main site and the other for the Stroke Center Network’s non-member pages. The Stroke Research Summary was last updated on December 4 1998.

Register

Site

National Stroke Association (NSA)

Content

The Stroke Research Summary consists of a listing of about 30 clinical trials. Sources of information vary from pharmaceutical companies and individual hospital centers to journals and websites, such as PhRMA New Medicines in Development. Some provide very little detail, others more. The sponsor/co-ordinating center is named only, without full contact details.(Paid) membership of the Stroke Center Network allows ‘enrollment into NSA’s clinical trial data base and access to ongoing information and perspectives on clinical trials’. These services were not assessed during this site visit. Details are given of other benefits of membership.The NSA’s Stroke Center Network is an alliance of clinicians, researchers, and healthcare professionals who are committed to developing centers of excellence for stroke management.

Other information available

The site’s professional pages provide information on the NSA’s Clinical Trials Acceleration Program. A Treatment link on the home page gives access to a list of ‘Trial Agents for Acute Treatment’.The professional pages also give information on stroke prevention programs, professional meetings, fellowships, publications, educational materials and library services.

Access

Access to the main site is free, but the Stroke Center Network pages include an area for members only (membership fee payable and authorisation required).Access to the Stroke Research Summary page is via the ‘Professional Pages’ button, then click on Clinical Trials Acceleration Program, and the Stroke Research Summary link at the bottom of this page. Although the site states that the Stroke Research Summary is for professionals only, there is unrestricted access to it.

Comments

Paid membership of the Stroke Center Network confers access to more information on ongoing trials. There are two search facilities: one for the main site and the other for the Stroke Center Network’s non-member pages. The Stroke Research Summary was last updated on December 4 1998.